Pregnane X receptor: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 28: | Line 28: | ||
{{biology-stub}} | {{biology-stub}} | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
Revision as of 05:08, 11 February 2025
Pregnane X receptor (PXR), also known as the steroid and xenobiotic sensing nuclear receptor (SXR), is a protein that in humans is encoded by the NR1I2 (nuclear receptor subfamily 1, group I, member 2) gene. PXR is a member of the nuclear receptor family of transcription factors and is activated by a variety of compounds and drugs.
Function
Pregnane X receptor plays a central role in the body's defense against potentially harmful, foreign chemicals. It is primarily expressed in the liver and intestine, two major sites of xenobiotic detoxification. PXR regulates the expression of Phase I and Phase II enzymes, as well as drug transporters, which are involved in the metabolism and elimination of various potentially harmful compounds.
Ligands
Pregnane X receptor is activated by a wide range of chemicals. These include not only prescription drugs, such as rifampicin and paclitaxel, but also dietary supplements, herbal remedies, and even compounds found in the environment. This broad ligand specificity is thought to be a result of the large and flexible ligand-binding pocket of PXR.
Clinical significance
Given its role in drug metabolism, PXR is of significant clinical interest. Variations in the PXR gene can affect an individual's response to drugs, potentially leading to adverse drug reactions or therapeutic failure. Furthermore, PXR activation has been implicated in drug-drug interactions, as well as in the development of certain diseases, such as cancer and metabolic syndrome.
See also
References
<references group="" responsive="1"></references>
